A genome-wide association study of renal cell carcinoma among African Americans

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 1, 2014, Pages 209-214

  Purdue, Mark P ^a   Ye, Yuanqing ^b   Wang, Zhaoming ^a   Colt, Joanne S ^a   Schwartz, Kendra L ^c   Davis, Faith G ^d   Rothman, Nathaniel ^a   Chow, Wong Ho ^b   Wu, Xifeng ^b   Chanock, Stephen J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONFIDENCE INTERVAL; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HISTOLOGY; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; KIDNEY NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84892759742     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0818     Document Type: Article

References (19)

1. Lynch CF, West MM, Davila JA, Platz CE. Cancers of the kidney and renal pelvis. In: Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J, editors. SEER survival monograph: cancer survival among adults: U.S. SEER Program, 1988-2001, patient and tumor characteristics. Bethesda, MD: National Cancer Institute, SEER Program; 2007. p. 193-202.
2. Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol 2010;7:1-13.
3. Olshan AF, Kuo TM, Meyer AM, Nielsen ME, Purdue MP, Rathmell WK. Racial difference in histologic subtype of renal cell carcinoma. Cancer Med 2013;2:744-9.
4. Karami S, Schwartz K, Purdue MP, Davis FG, Ruterbusch JJ, Munuo SS, et al. Family history of cancer and renal cell cancer risk in Caucasians and African Americans. Br J Cancer 2010;102:1676-80.
5. Linehan WM, Srinivasan R, Schmidt LS. The genetic basis of kidney cancer: a metabolic disease. Nat Rev Urol 2010;7:277-85.
6. Purdue MP, Johansson M, Zelenika D, Toro JR, Scelo G, Moore LE, et al. Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet 2011;43:60-5.
7. Wu X, Scelo G, Purdue MP, Rothman N, Johansson M, Ye Y, et al. A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23. Hum Mol Genet 2012;21:456-62.
8. Henrion M, Frampton M, Scelo G, Purdue M, Ye Y, Broderick P, et al. Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer. Hum Mol Genet 2013;22:825-31.
9. Schodel J, Bardella C, Sciesielski LK, Brown JM, Pugh CW, Buckle V, et al. Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression. Nat Genet 2012;44:420-2.
10. Heid IM, Jackson AU, Randall JC, Winkler TW, Qi L, Steinthorsdottir V, et al. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet 2010;42:949-60.
11. Colt JS, Schwartz K, Graubard BI, Davis F, Ruterbusch J, Digaetano R, et al. Hypertension and risk of renal cell carcinoma among white and black Americans. Epidemiology 2011;22:797-804.
12. Yu K, Wang Z, Li Q, Wacholder S, Hunter DJ, Hoover RN, et al. Population substructure and control selection in genome-wide association studies. PLoS ONE 2008;3:e2551.
13. Falush D, Stephens M, Pritchard JK. Inference of population structure using multilocus genotype data: dominant markers and null alleles. Mol Ecol Notes 2007;7:574-8.
14. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genomewide association studies. Nat Genet 2006;38:904-9.
15. de Bakker PI, Ferreira MA, Jia X, Neale BM, Raychaudhuri S, Voight BF. Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum Mol Genet 2008;17:R122-R128.
16. Begg CB, Zhang ZF. Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev 1994;3:173-5.
17. Bindra RS, Vasselli JR, Stearman R, Linehan WM, Klausner RD. VHLmediated hypoxia regulation of cyclin D1 in renal carcinoma cells. Cancer Res 2002;62:3014-9.
18. Zatyka M, da Silva NF, Clifford SC, Morris MR, Wiesener MS, Eckardt KU, et al. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease. Cancer Res 2002;62:3803-11.
19. Baba M, Hirai S, Yamada-Okabe H, Hamada K, Tabuchi H, Kobayashi K, et al. Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through hypoxia-inducible factor. Oncogene 2003;22:2728-38.